Safety and Efficacy of Denosumab vs Risedronate in Patients With Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis
Adachi J, et al.
Below is a selection of Amgen data presentations at ACR 2021. For information on other Amgen data presentations at ACR 2021, please contact Medical Information.
Adachi J, et al.
Bykerk V, et al.
Curtis JR, et al.
Lin T, et al.
Mease PJ, et al.
Tchao N, et al.
This video provides a brief explanation of the basic tenets of extrapolation as it pertains to biosimilars. (0:50)
This video provides a high-level overview of what a biological drug is and how it differs from a small molecule drug. (0:47)
This video provides a high-level overview of biosimilars. The main goal of biosimilars is to create a drug that is similar to a reference product. (0:42)
See how Otezla may work in psoriatic arthritis. The specific mechanism(s) by which apremilast exerts its therapeutic action is not well defined. (3:30)
Learn about the PALACE 4 clinical trial data in DMARD-naïve patients. (11:52)
Learn about the RELIEF clinical trial data. (11:14)
Learn about the MOA for EVENITY® (romosozumab-aqqg) in treatment of post-menopausal women who are at high risk of fracture.
Learn more about the Prolia® MOA for treatment of post-menopausal osteoporosis.
Watch Dr. Amar Majjhoo discuss the results of the SEAM-RA clinical trial on ENBREL as a monotherapy for maintaining remission in patients with moderate-to-severe Rheumatoid Arthritis. (29:06)
Watch Dr. Lawrence Leventhal discuss the results of the SEAM-PsA clinical trial on ENBREL as a monotherapy for treating patients with PsA. (19:36)
The Embark App provides patients with financial support information, medication reminders, injection site tracking & more—all in the palm of their hand. (4:05)
Watch a video about ENBREL Nurse Partners™ and how they can help your patient prepare for their first injection at home with supplemental support. (2:44)
Watch a video about ENBREL Support® services that provides helpful information for your patients on prescribed ENBREL therapy. (2:22)